Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ONMD
ONMD logo

ONMD Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Onemednet Corp (ONMD) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
0.760
1 Day change
-4.90%
52 Week Range
4.220
Analysis Updated At
2026/03/20
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Onemednet Corp (ONMD) is not a strong buy at this moment for a beginner investor with a long-term focus. The stock shows no significant trading trends, lacks positive news catalysts, and has weak financial performance. While technical indicators are neutral, there is no strong signal to suggest immediate entry.

Technical Analysis

The MACD is above 0 and positively contracting, indicating slight bullish momentum, but the RSI is neutral at 54.595. The stock is trading near its pivot at 0.75, with resistance at 0.847 and support at 0.653. Overall, the technical indicators do not provide a strong buy signal.

Positive Catalysts

  • Revenue increased by 24.65% YoY in Q3 2025, showing some growth potential.

Neutral/Negative Catalysts

  • Net income dropped by 63.99% YoY, EPS fell by 85.71%, and gross margin remains negative at -125.42%. No recent news or significant trading trends from hedge funds, insiders, or Congress.

Financial Performance

In Q3 2025, revenue increased to $177,000 (up 24.65% YoY), but net income dropped to -$741,000 (down 63.99% YoY). EPS fell to -0.01 (down 85.71% YoY), and gross margin remains deeply negative at -125.42%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No data available on analyst ratings or price target changes.

Wall Street analysts forecast ONMD stock price to rise
Analyst Rating
0
Wall Street analysts forecast ONMD stock price to rise
Buy
Hold
Sell
0
Current: 0.795
sliders
Low
0
Averages
0
High
0
0
Current: 0.795
sliders
Low
0
Averages
0
High
0
No data

No data

People Also Watch